Injection of nerve growth factor into human masseter muscle evokes long-lasting mechanical allodynia and hyperalgesia

Pain

Volumn 104, Issue 1-2, 2003, Pages 241-247

  Svensson, Peter ^a,b   Cairns, Brian E ^c   Wang, Kelun ^d   Arendt Nielsen, Lars ^d  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d AALBORG UNIVERSITY   (Denmark)

Author keywords

Allodynia; Nerve growth factor; Orofacial pain; Pain measurement; Temporomandibular disorders pain

Indexed keywords

BUFFER; ISOTONIC SOLUTION; NERVE GROWTH FACTOR; PLACEBO; SODIUM CHLORIDE;

ADAPTATION; ADULT; ALLODYNIA; ANALYSIS OF VARIANCE; ARTICLE; CONTROLLED STUDY; DRINKING; FACIAL EXPRESSION; FEVER; HUMAN; HUMAN EXPERIMENT; HYPERALGESIA; INJECTION; JAW; JAW MOVEMENT; MALE; MASSETER MUSCLE; MASTICATION; NOCICEPTION; NORMAL HUMAN; PAIN THRESHOLD; PRESSURE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REST; SCORING SYSTEM; SWALLOWING; TEMPORALIS MUSCLE; YAWNING;

EID: 0037823440     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00012-5     Document Type: Article

References (45)

1. Apfel S.C., Kessler J.A., Adornato B.T., Litchy W.J., Sanders C., Rask C.A. Recombinant human nerve growth factor in the treatment of diabetic polyneuropathy. Neurology. 51:1998;662-663.
2. Apfel S.C., Schwartz S., Adornato B.T., Freeman R., Biton V., Rendell M., Vinik A., Giuliani M., Stevens J.C., Barbano R., Dyck P.J. Efficacy and safety of recombinant human nerve growth factor in patients with diabetic polyneuropathy: a randomized controlled trial. J Am Med Assoc. 284:2000;2215-2221.
3. Apfel S.C. Neurotrophic factors and pain. Clin J Pain. 16:2000;S7-S11.
4. Arima T., Svensson P., Arendt-Nielsen L. Experimental grinding in healthy subjects: a model for postexercise jaw muscle soreness? J Orofac Pain. 13:1999;104-114.
5. Babenko V., Svensson P., Graven-Nielsen T., Drewes A.M., Jensen T.S., Arendt-Nielsen L. Duration and distribution of experimental muscular hyperalgesia in humans following combined infusions of serotonin and bradykinin. Brain Res. 853:2000;275-281.
6. Bennett D.L.H. Neurotrophic factors: important regulators of nociceptive function. Neuroscientist. 7:2001;13-17.
7. Bereiter D.A. Sex differences in brainstem neural activation after injury to the TMJ region. Cells Tissues Organs. 169:2001;226-237.
8. Bergmann I., Reiter R., Toyka K.V., Koltzenburg M. Nerve growth factor evokes hyperalgesia in mice lacking the low-affinity neurotrophin receptor p75. Neurosci Lett. 255:1998;87-90.
9. Bjorling D.E., Wang Z. Estrogen and neuroinflammation. Urology. 57:2001;40-46.
10. Broton J.G., Sessle B.J. Reflex excitation of masticatory muscles induced by algesic chemicals applied to the temporomandibular joint of the cat. Arch Oral Biol. 33:1988;741-747.
11. Cairns B.E., Gambarota G., Svensson P., Arendt-Nielsen L., Berde C.B. Glutamate-induced sensitization of rat masseter muscle fibers. Neuroscience. 109:2002;389-399.
12. Cairns B.E., Hu J.W., Arendt-Nielsen L., Sessle B.J., Svensson P. Sex-related differences in human pain and rat afferent discharge evoked by injection of glutamate into the masseter muscle. J Neurophysiol. 86:2001;782-791.
13. Cairns B.E., Sessle B.J., Hu J.W. Evidence that excitatory amino acid receptors within the temporomandibular joint region are involved in the reflex activation of the jaw muscles. J Neurosci. 18:1998;8056-8064.
14. Cairns B.E., Sim Y.-L., Bereiter D.A., Sessle B.J., Hu J.W. Influence of sex on reflex jaw muscle activity evoked from the rat temporomandibular joint. Brain Res. 957:2002;338-344.
15. De Boever J.A., Carlsson G.E. Etiology and differential diagnosis. Zarb G.A., Carlsson G.E., Sessle B.J., Mohl N.D. Temporomandibular joint and masticatory muscle disorders. 1994;171-187 Munksgaard, Copenhagen.
16. Di Luca M., Gardoni F., Finardi A., Pagliardini S., Cattabeni F., Battaglia G., Missale C. NMDA receptor subunits are phosphorylated by activation of neurotrophin receptors in PSD of rat spinal cord. NeuroReport. 12:2001;1301-1305.
17. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord Facial Oral Pain. 6:1992;301-355.
18. Dyck P.J., Peroutka S., Rask C., Burton E., Baker M.K., Lehman K.A., Gillen D.A., Hokanson J.L., O'Brien P.C. Intradermal recombinant human nerve growth factor induces pressure allodynia and lowered heat-pain threshold in humans. Neurology. 48:1997;501-505.
19. Giovengo S.L., Russell I.J., Larson A.A. Increased concentrations of nerve growth factor in cerebrospinal fluid of patients with fibromyalgia. J Rheumatol. 26:1999;1564-1569.
20. Hao J., Ebendal T., Xu X., Wiesenfeld-Hallin Z., Eriksdotter J., Jonhagen M. Intracerebroventricular infusion of nerve growth factor induces pain-like response in rats. Neurosci Lett. 286:2000;208-212.
21. Isselee H., De Laat A., Bogaerts K., Lysens R. Long-term fluctuations of pressure pain thresholds in healthy men, normally menstruating women and oral contraceptive users. Eur J Pain. 5:2001;27-37.
22. Jarvis C.R., Xiong Z.G., Plant J.R., Churchill D., Lu W.Y., MacVicar B.A., MacDonald J.F. Neurotrophin modulation of NMDA receptors in cultured murine and isolated rat neurons. J Neurophysiol. 78:1997;2363-2371.
23. Jensen K., Andersen H.O., Olesen J., Lindblom U. Pressure-pain threshold in human temporal region: evaluation of a new pressure algometer. Pain. 25:1986;313-323.
24. Kopp S. Neuroendocrine, immune, and local responses related to temporomandibular disorders. J Orofac Pain. 15:2001;9-28.
25. LeResche L. Research diagnostic criteria for temporomandibular disorders. Adv Pain Res Ther. 21:1995;189-203.
26. Lewin G.R., Mendell L.M. Nerve growth factor and nociception. Trends Neurosci. 16:1993;353-359.
27. Lewin G.R., Ritter A.M., Mendell L.M. Nerve growth factor-induced hyperalgesia in the neonatal and adult rat. J Neurosci. 13:1993;2136-2148.
28. Lewin G.R., Rueff A., Mendell L.M. Peripheral and central mechanisms of NGF-induced hyperalgesia. Eur J Neurosci. 6:1994;1903-1912.
29. Liuzzi F.J., Scoville S.A., Bufton S.M. Effects of short-term estrogen replacement on trkA mRNA levels in axotomized dorsal root ganglion neurons. Exp Neurol. 159:1999;433-440.
30. McLeod A.L., Ritchie J., Cuello A.C., Julien J.P., Ribeiro-Da-Silva A., Henry J.L. Transgenic mice over-expressing substance P exhibit allodynia and hyperalgesia which are reversed by substance P and N-methyl-D-aspartate receptor antagonists. Neuroscience. 89:1999;891-899.
31. McMahon S.B., Bennett D.L., Priestley J.V., Shelton D.L. The biological effects of endogenous nerve growth factor on adult sensory neurons revealed by a trkA-IgG fusion molecule. Nat Med. 1:1995;774-780.
32. Ohrbach R., Crow H., Kamer A. Examiner expectancy effects in the measurement of pressure pain thresholds. Pain. 74:1998;163-170.
33. Petty B.G., Cornblath D.R., Adornato B.T., Chaudhry V., Flexner C., Wachsman M., Sinicropi D., Burton L.E., Peroutka S.J. The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol. 36:1994;244-246.
34. Rueff A., Mendell L.M. Nerve growth factor NT-5 induce increased thermal sensitivity of cutaneous nociceptors in vitro. J Neurophysiol. 76:1996;3593-3596.
35. Sarchielli P., Alberti A., Floridi A., Gallai V. Levels of nerve growth factor in cerebrospinal fluid of chronic daily headache patients. Neurology. 57:2001;132-134.
36. Sohrabji F., Miranda R.C., Toran-Allerand C.D. Estrogen differentially regulates estrogen and nerve growth factor receptor mRNAs in adult sensory neurons. J Neurosci. 14:1994;459-471.
37. Stohler C.S. Masticatory myalgias. Emphasis on the nerve growth factor - estrogen link. Pain Forum. 6:1997;176-180.
38. Svensson P., Arendt-Nielsen L., Nielsen H., Larsen J.K. Effect of chronic and experimental jaw muscle pain on pressure-pain thresholds and stimulus-response curves. J Orofac Pain. 9:1995;347-356.
39. Svensson P., Cairns B.E., Wang K., Hu J.W., Graven-Nielsen T., Arendt-Nielsen L., Sessle B.J. Glutamate-evoked pain and mechanical allodynia in the human masseter muscle. Pain. 101:2003;221-227.
40. Tal M., Liberman R. Local injection of nerve growth factor (NGF) triggers degranulation of mast cells in rat paw. Neurosci Lett. 221:1997;129-132.
41. Thompson S.W., Dray A., McCarson K.E., Krause J.E., Urban L. Nerve growth factor induces mechanical allodynia associated with novel A fibre-evoked spinal reflex activity and enhanced neurokinin-1 receptor activation in the rat. Pain. 62:1995;219-231.
42. Tsen L.C., Natale M., Datta S., Eappen S. Can estrogen influence the response to noxious stimuli? J Clin Anesth. 13:2001;118-121.
43. Warren M.P., Fried J.L. Temporomandibular disorders and hormones in women. Cells Tissues Organs. 169:2001;178-192.
44. Watanabe M., Tabata T., Huh J.I., Inai T., Tsuboi A., Sasaki K., Endo Y. Possible involvement of histamine in muscular fatigue in temporomandibular disorders: animal and human studies. J Dent Res. 78:1999;769-775.
45. Yu X.-M., Sessle B.J., Vernon H., Hu J.W. Effects of inflammatory irritant application to the rat temporomandibular joint on jaw and neck muscle activity. Pain. 60:1995;143-149.